Published in Chem Biol Drug Des on February 01, 2017
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res (1976) 4.60
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer (2001) 4.49
How does photodynamic therapy work? Photochem Photobiol (1992) 4.49
An update on photodynamic therapy applications. J Clin Laser Med Surg (2002) 2.94
The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol (1991) 2.50
State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B (2002) 2.19
Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem (2004) 2.02
The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res (1998) 2.00
Photosensitizers in clinical PDT. Photodiagnosis Photodyn Ther (2004) 1.97
Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res (2003) 1.48
Biological inactivation by singlet oxygen: distinguishing O2(1 delta g) and O2(1 sigma g+) Biochim Biophys Acta (1992) 1.43
Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photosensitizers directed to lysosomes versus mitochondria. Photochem Photobiol (2009) 1.31
WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model. Photochem Photobiol (2005) 1.21
Biological activities of phthalocyanines--VIII. Cellular distribution in V-79 Chinese hamster cells and phototoxicity of selectively sulfonated aluminum phthalocyanines. Photochem Photobiol (1988) 1.11
Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob Agents Chemother (2010) 1.10
Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. J Control Release (2010) 1.09
Components of hematoporphyrin derivatives and their tumor-localizing capacity. Cancer Res (1982) 1.08
Structure-activity relationship of porphines for photoinactivation of bacteria. Photochem Photobiol (1995) 1.07
Conjugation of 2-(1'-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo. J Med Chem (2009) 1.07
Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiat Res (1986) 1.04
Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light. Br J Cancer (1999) 1.01
Chemistry of hematoporphyrin-derived photosensitizers. Photochem Photobiol (1987) 0.98
In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers. J Med Chem (2010) 0.98
Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent. Cancer Chemother Pharmacol (1999) 0.97
Clinical pharmacokinetics of verteporfin. J Clin Pharmacol (2002) 0.97
Photodynamic therapy. Trends Biotechnol (1995) 0.95
Quantitation of Cremophor EL in human plasma samples using a colorimetric dye-binding microassay. Anal Biochem (1998) 0.93
The role of molecular oxygen in the photodynamic effect of phthalocyanines. Radiat Res (1986) 0.92
Protein oxidation and proteolysis by the nonradical oxidants singlet oxygen or peroxynitrite. Free Radic Biol Med (2001) 0.91
Hydrogen peroxide, superoxide, and hydroxyl radicals are involved in the phototoxic action of hematoporphyrin derivative against tumor cells. J Environ Pathol Toxicol Oncol (2006) 0.91
Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics. Br J Cancer (2003) 0.91
Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. J Control Release (2008) 0.89
Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells. J Pharm Sci (2013) 0.88
Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Cancer Res (1999) 0.88
Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin II and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor. Int J Cancer (1991) 0.87
Photocytotoxic efficacy of sulphonated species of aluminium phthalocyanine against cell monolayers, multicellular spheroids and in vivo tumours. Br J Cancer (1991) 0.87
Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery. ChemMedChem (2012) 0.87
Probing the structure and stability of the tumor-localizing derivative of hematoporphyrin by reductive cleavage with LiAlH4. Cancer Res (1987) 0.85
Vascular targeted photodynamic therapy for localized prostate cancer. Rev Urol (2008) 0.85
Pharmacokinetics of Photogem using fluorescence monitoring in Wistar rats. J Photochem Photobiol B (2004) 0.84
The localization and photosensitization of modified chlorin photosensitizers in artificial membranes. Photochem Photobiol Sci (2009) 0.84
Confocal fluorescence imaging enables noninvasive quantitative assessment of host cell populations in vivo following photodynamic therapy. Theranostics (2012) 0.84
Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J Control Release (2011) 0.84
Photosensitization with derivatives of haematoporphyrin. Int J Radiat Biol Relat Stud Phys Chem Med (1986) 0.83
Production of hydroxyl radicals in cell systems exposed to haematoporphyrin and red light. Int J Radiat Biol Relat Stud Phys Chem Med (1980) 0.83
Analysis of the in vivo and in vitro effects of photodynamic therapy on breast cancer by using a sensitizer, sinoporphyrin sodium. Theranostics (2015) 0.82
Thermosensitive liposome formulated indocyanine green for near-infrared triggered photodynamic therapy: in vivo evaluation for triple-negative breast cancer. Pharm Res (2014) 0.82
Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation. Int J Cancer (2015) 0.81
Chlorin e6 derivative radachlorin mainly accumulates in mitochondria, lysosome and endoplasmic reticulum and shows high affinity toward tumors in nude mice in photodynamic therapy. Photochem Photobiol (2014) 0.80
The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice. Invest New Drugs (2012) 0.80
Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing Balb/c mice using graphite furnace atomic absorption spectroscopy. Photochem Photobiol Sci (2004) 0.80
Purification and analysis of hematoporphyrin and hematoporphyrin derivative by gel exclusion and reverse-phase chromatography. Photochem Photobiol (1987) 0.79
Photophysical properties and in vitro and in vivo photoinduced antitumor activity of cationic salts of meso-tetrakis(N-alkyl-3-pyridyl)bacteriochlorins. J Photochem Photobiol B (2013) 0.79
131I-Zn-Chlorophyll derivative photosensitizer for tumor imaging and photodynamic therapy. Int J Pharm (2015) 0.79
Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective in vitro photodynamic activity against cancer cells at low nanomolar concentration. J Porphyr Phthalocyanines (2013) 0.78
Photodynamic therapy of the ciliary body with tin ethyl etiopurpurin and tin octaethyl benzochlorin in pigmented rabbits. Ophthalmic Surg Lasers (1997) 0.78
Biological activities of phthalocyanines--XI. Phototoxicity of sulfonated aluminum naphthalocyanines towards V-79 Chinese hamster cells. Photochem Photobiol (1990) 0.78
Biodistribution and phototherapeutic properties of Zinc (II) 2,9,16,23-tetrakis (methoxy) phthalocyanine in vivo. Photodiagnosis Photodyn Ther (2009) 0.78
On the purity and definition of oligomeric HPD formulations. J Photochem Photobiol B (1989) 0.78
Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6. Retina (2001) 0.78
Lipoprotein-mediated distribution of N-aspartyl chlorin-E6 in the mouse. Photochem Photobiol (1992) 0.77
Probing the structure of HPD by fluorescence spectroscopy. Photochem Photobiol (1989) 0.77
Conjugated PDT drug: photosensitizing activity and tissue distribution of PEGylated pheophorbide a. Cancer Biol Ther (2010) 0.77
Biodistribution assessment of a lutetium(III) texaphyrin analogue in tumor-bearing mice using NIR Fourier-transform Raman spectroscopy. Photochem Photobiol (2004) 0.76
Effects of ursodeoxycholic acid on photodynamic therapy in a murine tumor model. Photochem Photobiol (2003) 0.76
Antitumor activity of photodynamic therapy with a chlorin derivative in vitro and in vivo. Tumour Biol (2015) 0.76
The role of lipoproteins in the distribution of tin etiopurpurin (SnET2) in the tumor-bearing rat. Photochem Photobiol (1993) 0.76
In vitro and in vivo photodynamic activity of core-modified porphyrin IY69 using 690 nm diode laser. Photochem Photobiol (2011) 0.76
Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria. Bioorg Med Chem (2012) 0.76
Assessment of a sheep animal model to optimise photodynamic therapy in the oesophagus. Lasers Surg Med (2009) 0.76
Evaluation of cancer imaging potential and photodynamic therapy efficacy of copper (II) benzyloxypheophorbide-a. J Drug Target (2014) 0.76
pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78
Photobiomodulation or low-level laser therapy. J Biophotonics (2016) 0.77
T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it? Photochem Photobiol Sci (2015) 0.77
Photobiomodulation and the brain: a new paradigm. J Opt (2016) 0.75